271 filings
8-K
TXMD
TherapeuticsMD, Inc.
20 Sep 24
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:00pm
8-K
TXMD
TherapeuticsMD, Inc.
12 Aug 24
TherapeuticsMD Announces Second Quarter 2024 Financial Results
4:10pm
8-K
TXMD
TherapeuticsMD, Inc.
10 May 24
TherapeuticsMD Announces First Quarter 2024 Financial Results
4:15pm
8-K
TXMD
TherapeuticsMD, Inc.
29 Mar 24
TherapeuticsMD Announces Full Year 2023 Financial Results
4:29pm
8-K
TXMD
TherapeuticsMD, Inc.
14 Nov 23
TherapeuticsMD Announces Third Quarter 2023 Financial Results
4:25pm
8-K
6klcan3cznu27s
18 Aug 23
Entry into a Material Definitive Agreement
5:18pm
8-K
1zuftnoz
14 Aug 23
TherapeuticsMD Announces Second Quarter 2023 Financial Results
7:15am
8-K
b2b4b wtxkax0
10 Jul 23
Changes in Registrant's Certifying Accountant
5:20pm
8-K
9flyiw9h6u
6 Jul 23
Unregistered Sales of Equity Securities
4:38pm
8-K
pepbzv
28 Jun 23
Submission of Matters to a Vote of Security Holders
7:00am
8-K
4shjj0
15 May 23
TherapeuticsMD Announces First Quarter 2023 Financial Results
4:16pm
8-K
8j8 xtpdym
5 May 23
Entry into a Material Definitive Agreement
5:26pm
8-K
diu7jm lbqlbyiqq9b
21 Apr 23
Other Events
5:14pm
8-K
68im4p5 9n618a
7 Apr 23
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
4:41pm
8-K
f8i5ym
27 Feb 23
Departure of Directors or Certain Officers
4:27pm
8-K
jpztnmmja5drrf
18 Jan 23
Departure of Directors or Certain Officers
5:00pm
8-K
0om95 v53gxw9
12 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K/A
yyztupc dvx6ol0wqr
6 Jan 23
Departure of Directors or Certain Officers
5:30pm
8-K
0b57ec03u
3 Jan 23
TherapeuticsMD Completes Transaction to License its Products to Mayne Pharma
7:00am
8-K
1noji
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am